Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Jeanne Emmons"'
Autor:
Mazen Issa, Dawn B. Beaulieu, David G. Binion, Susan Skaros, Joshua F. Knox, Ashwin N. Ananthakrishnan, Mary F. Otterson, Sarah J. Lundeen, Jeanne Emmons, Kathryn Lemke
Publikováno v:
Inflammatory Bowel Diseases. 15:176-181
Background: Patients who require hospitalization for the management of ulcerative colitis (UC) may represent a subset with severe disease. These patients may be more likely to require future colectomy. There are limited data examining whether medical
Autor:
Randall S. Kuhlmann, Sue Skaros, Josh F. Knox, Mary F. Otterson, Julianne Newcomer, Lydia Rosenbaum, Jeanne Emmons, Ashwin N. Ananthakrishnan, Mazen Issa, David G. Binion, Dawn B. Beaulieu
Publikováno v:
Inflammatory Bowel Diseases. 15:25-28
Background: There is no standard approach for the medical management of Crohn's disease (CD) during pregnancy and there is limited data regarding safety and efficacy of the treatments. Budesonide (Entocort® EC, AstraZeneca) is an enteric coated loca
Autor:
Ashwin N. Ananthakrishnan, Jeanne Emmons, Mary F. Otterson, Josh F. Knox, Susan Skaros, Mazen Issa, Lydia R. Weber, Sarah J. Lundeen, David G. Binion
Publikováno v:
The American Journal of Gastroenterology. 103:154-161
OBJECTIVE: Crohn's disease (CD) frequently presents during early adulthood, a peak time of work productivity. There are limited data from the United States on work disability from CD. We performed this study to identify clinical factors associated wi
Autor:
Kia Saeian, Joshua F. Knox, Devang Prajapati, Mary Ellen Csuka, Jeanne Emmons, David G. Binion
Publikováno v:
Journal of Clinical Gastroenterology. 37:125-128
Immunomodulator therapy with the purine analogs azathioprine and 6-mercaptopurine (6-MP), is efficacious in the treatment of moderate to severe Crohn's disease (CD), but is not tolerated by a significant minority of patients. The pyrimidine analog, l
Publikováno v:
Inflammatory Bowel Diseases. 8:192-195
Recent reports suggest that unfractionated heparin may be a useful adjunct in the treatment of inflammatory bowel disease (IBD). We report the successful use of subcutaneous unfractionated heparin to treat a moderate-to-severe flare of Crohn's diseas
Autor:
Kia Saiean, Jeanne Emmons, William L. Berger, Majed Abu-Hajir, Sotirios Vasilopoulos, David G. Binion, Bellur Seetharam
Publikováno v:
Journal of Clinical Gastroenterology. 33:132-136
BACKGROUND Elevated plasma total homocysteine (tHcy) is associated with a higher risk of thrombosis. Crohn's disease (CD) is associated with hypercoagulability of undefined etiology. We investigated tHcy in patients with CD and its relationship with
Autor:
Jeanne Emmons, Dawn B. Beaulieu, David G. Binion, Mazen Issa, Mary Beth Graham, Lydia R. Weber, Jasmohan S. Bajaj, Richard A. Komorowski, Mary F. Otterson, Susan Skaros, Sarah J. Lundeen, Aravind Vijayapal, Josh F. Knox
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 5(3)
Clostridium difficile-associated disease has increased significantly in North American medical centers. The impact of C difficile on patients with IBD (Crohn's disease, ulcerative colitis) at the present time is unknown.A retrospective, observational
Autor:
Rajiv R. Varma, Jasmohan S. Bajaj, Judy Podoll, Michael J. Levy, Jeanne Emmons, Kia Saeian, David G. Binion, Joshua F. Knox, Jose Franco
Publikováno v:
The American journal of gastroenterology. 100(5)
Idiosyncratic drug hypersensitivity may occur at increased rates in specific patient populations. Azathioprine has a significant early adverse reaction (EAR) profile, which includes an acute syndrome of constitutional symptoms, fever, rash, and acute
Autor:
David G. Binion, Kia Saeian, Jeanne Emmons, Kevin J. Kelly, Alfonso Martinez, Sotirios Vasilopoulos, Michael B. Levy, Subra Kugathasan, Joseph P. Kim, Devang Prajapati
Publikováno v:
The American journal of gastroenterology. 97(6)
Although effective in the treatment of refractory Crohn's disease, episodic retreatment with the antitumor necrosis factor a chimeric monoclonal antibody infliximab (Remicade, Centocor, Malvern, PA) can be associated with severe acute and delayed sys
Autor:
Jeanne Emmons
Publikováno v:
Ecotone. 5:10-11